- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The NSAIDs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global NSAIDs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Back Pain Treatment accounting for % of the NSAIDs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Aspirin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of NSAIDs include Bayer, Novacap, Abbott, Pfizer, and Johnson & Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
NSAIDs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Market segment by Application can be divided into
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
The key market players for global NSAIDs market are listed below:
Bayer
Novacap
Abbott
Pfizer
Johnson & Johnson
Cigna
Geri-Care Pharmaceuticals
Perrigo Company
Kopran
Merck Sharp & Dohme
Sun Pharmaceutical Industries
GlaxoSmithKline
Reddy Pharmaceuticals
Verywell
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe NSAIDs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of NSAIDs, with price, sales, revenue and global market share of NSAIDs from 2019 to 2022.
Chapter 3, the NSAIDs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the NSAIDs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and NSAIDs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of NSAIDs.
Chapter 13, 14, and 15, to describe NSAIDs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 NSAIDs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global NSAIDs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Nabumetone
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global NSAIDs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Back Pain Treatment
1.3.3 Osteoarthritis Treatment
1.3.4 Other Disease Treatment
1.4 Global NSAIDs Market Size & Forecast
1.4.1 Global NSAIDs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global NSAIDs Sales in Volume (2017-2028)
1.4.3 Global NSAIDs Price (2017-2028)
1.5 Global NSAIDs Production Capacity Analysis
1.5.1 Global NSAIDs Total Production Capacity (2017-2028)
1.5.2 Global NSAIDs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 NSAIDs Market Drivers
1.6.2 NSAIDs Market Restraints
1.6.3 NSAIDs Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer NSAIDs Product and Services
2.1.4 Bayer NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Novacap
2.2.1 Novacap Details
2.2.2 Novacap Major Business
2.2.3 Novacap NSAIDs Product and Services
2.2.4 Novacap NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott NSAIDs Product and Services
2.3.4 Abbott NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer NSAIDs Product and Services
2.4.4 Pfizer NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson NSAIDs Product and Services
2.5.4 Johnson & Johnson NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Cigna
2.6.1 Cigna Details
2.6.2 Cigna Major Business
2.6.3 Cigna NSAIDs Product and Services
2.6.4 Cigna NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Geri-Care Pharmaceuticals
2.7.1 Geri-Care Pharmaceuticals Details
2.7.2 Geri-Care Pharmaceuticals Major Business
2.7.3 Geri-Care Pharmaceuticals NSAIDs Product and Services
2.7.4 Geri-Care Pharmaceuticals NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Perrigo Company
2.8.1 Perrigo Company Details
2.8.2 Perrigo Company Major Business
2.8.3 Perrigo Company NSAIDs Product and Services
2.8.4 Perrigo Company NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Kopran
2.9.1 Kopran Details
2.9.2 Kopran Major Business
2.9.3 Kopran NSAIDs Product and Services
2.9.4 Kopran NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Merck Sharp & Dohme
2.10.1 Merck Sharp & Dohme Details
2.10.2 Merck Sharp & Dohme Major Business
2.10.3 Merck Sharp & Dohme NSAIDs Product and Services
2.10.4 Merck Sharp & Dohme NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Sun Pharmaceutical Industries
2.11.1 Sun Pharmaceutical Industries Details
2.11.2 Sun Pharmaceutical Industries Major Business
2.11.3 Sun Pharmaceutical Industries NSAIDs Product and Services
2.11.4 Sun Pharmaceutical Industries NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 GlaxoSmithKline
2.12.1 GlaxoSmithKline Details
2.12.2 GlaxoSmithKline Major Business
2.12.3 GlaxoSmithKline NSAIDs Product and Services
2.12.4 GlaxoSmithKline NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Reddy Pharmaceuticals
2.13.1 Reddy Pharmaceuticals Details
2.13.2 Reddy Pharmaceuticals Major Business
2.13.3 Reddy Pharmaceuticals NSAIDs Product and Services
2.13.4 Reddy Pharmaceuticals NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Verywell
2.14.1 Verywell Details
2.14.2 Verywell Major Business
2.14.3 Verywell NSAIDs Product and Services
2.14.4 Verywell NSAIDs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 NSAIDs Breakdown Data by Manufacturer
3.1 Global NSAIDs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global NSAIDs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in NSAIDs
3.4 Market Concentration Rate
3.4.1 Top 3 NSAIDs Manufacturer Market Share in 2021
3.4.2 Top 6 NSAIDs Manufacturer Market Share in 2021
3.5 Global NSAIDs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and NSAIDs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global NSAIDs Market Size by Region
4.1.1 Global NSAIDs Sales in Volume by Region (2017-2028)
4.1.2 Global NSAIDs Revenue by Region (2017-2028)
4.2 North America NSAIDs Revenue (2017-2028)
4.3 Europe NSAIDs Revenue (2017-2028)
4.4 Asia-Pacific NSAIDs Revenue (2017-2028)
4.5 South America NSAIDs Revenue (2017-2028)
4.6 Middle East and Africa NSAIDs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global NSAIDs Sales in Volume by Type (2017-2028)
5.2 Global NSAIDs Revenue by Type (2017-2028)
5.3 Global NSAIDs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global NSAIDs Sales in Volume by Application (2017-2028)
6.2 Global NSAIDs Revenue by Application (2017-2028)
6.3 Global NSAIDs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America NSAIDs Sales by Type (2017-2028)
7.2 North America NSAIDs Sales by Application (2017-2028)
7.3 North America NSAIDs Market Size by Country
7.3.1 North America NSAIDs Sales in Volume by Country (2017-2028)
7.3.2 North America NSAIDs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe NSAIDs Sales by Type (2017-2028)
8.2 Europe NSAIDs Sales by Application (2017-2028)
8.3 Europe NSAIDs Market Size by Country
8.3.1 Europe NSAIDs Sales in Volume by Country (2017-2028)
8.3.2 Europe NSAIDs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific NSAIDs Sales by Type (2017-2028)
9.2 Asia-Pacific NSAIDs Sales by Application (2017-2028)
9.3 Asia-Pacific NSAIDs Market Size by Region
9.3.1 Asia-Pacific NSAIDs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific NSAIDs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America NSAIDs Sales by Type (2017-2028)
10.2 South America NSAIDs Sales by Application (2017-2028)
10.3 South America NSAIDs Market Size by Country
10.3.1 South America NSAIDs Sales in Volume by Country (2017-2028)
10.3.2 South America NSAIDs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa NSAIDs Sales by Type (2017-2028)
11.2 Middle East & Africa NSAIDs Sales by Application (2017-2028)
11.3 Middle East & Africa NSAIDs Market Size by Country
11.3.1 Middle East & Africa NSAIDs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa NSAIDs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of NSAIDs and Key Manufacturers
12.2 Manufacturing Costs Percentage of NSAIDs
12.3 NSAIDs Production Process
12.4 NSAIDs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 NSAIDs Typical Distributors
13.3 NSAIDs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global NSAIDs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global NSAIDs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer NSAIDs Product and Services
Table 6. Bayer NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Novacap Basic Information, Manufacturing Base and Competitors
Table 8. Novacap Major Business
Table 9. Novacap NSAIDs Product and Services
Table 10. Novacap NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Abbott Basic Information, Manufacturing Base and Competitors
Table 12. Abbott Major Business
Table 13. Abbott NSAIDs Product and Services
Table 14. Abbott NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer NSAIDs Product and Services
Table 18. Pfizer NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Major Business
Table 21. Johnson & Johnson NSAIDs Product and Services
Table 22. Johnson & Johnson NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Cigna Basic Information, Manufacturing Base and Competitors
Table 24. Cigna Major Business
Table 25. Cigna NSAIDs Product and Services
Table 26. Cigna NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Geri-Care Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Geri-Care Pharmaceuticals Major Business
Table 29. Geri-Care Pharmaceuticals NSAIDs Product and Services
Table 30. Geri-Care Pharmaceuticals NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Perrigo Company Basic Information, Manufacturing Base and Competitors
Table 32. Perrigo Company Major Business
Table 33. Perrigo Company NSAIDs Product and Services
Table 34. Perrigo Company NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Kopran Basic Information, Manufacturing Base and Competitors
Table 36. Kopran Major Business
Table 37. Kopran NSAIDs Product and Services
Table 38. Kopran NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Merck Sharp & Dohme Basic Information, Manufacturing Base and Competitors
Table 40. Merck Sharp & Dohme Major Business
Table 41. Merck Sharp & Dohme NSAIDs Product and Services
Table 42. Merck Sharp & Dohme NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharmaceutical Industries Major Business
Table 45. Sun Pharmaceutical Industries NSAIDs Product and Services
Table 46. Sun Pharmaceutical Industries NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 48. GlaxoSmithKline Major Business
Table 49. GlaxoSmithKline NSAIDs Product and Services
Table 50. GlaxoSmithKline NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Reddy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. Reddy Pharmaceuticals Major Business
Table 53. Reddy Pharmaceuticals NSAIDs Product and Services
Table 54. Reddy Pharmaceuticals NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Verywell Basic Information, Manufacturing Base and Competitors
Table 56. Verywell Major Business
Table 57. Verywell NSAIDs Product and Services
Table 58. Verywell NSAIDs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global NSAIDs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 60. Global NSAIDs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in NSAIDs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global NSAIDs Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 63. Head Office and NSAIDs Production Site of Key Manufacturer
Table 64. NSAIDs New Entrant and Capacity Expansion Plans
Table 65. NSAIDs Mergers & Acquisitions in the Past Five Years
Table 66. Global NSAIDs Sales by Region (2017-2022) & (K Pcs)
Table 67. Global NSAIDs Sales by Region (2023-2028) & (K Pcs)
Table 68. Global NSAIDs Revenue by Region (2017-2022) & (USD Million)
Table 69. Global NSAIDs Revenue by Region (2023-2028) & (USD Million)
Table 70. Global NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 71. Global NSAIDs Sales by Type (2023-2028) & (K Pcs)
Table 72. Global NSAIDs Revenue by Type (2017-2022) & (USD Million)
Table 73. Global NSAIDs Revenue by Type (2023-2028) & (USD Million)
Table 74. Global NSAIDs Price by Type (2017-2022) & (USD/Pcs)
Table 75. Global NSAIDs Price by Type (2023-2028) & (USD/Pcs)
Table 76. Global NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 77. Global NSAIDs Sales by Application (2023-2028) & (K Pcs)
Table 78. Global NSAIDs Revenue by Application (2017-2022) & (USD Million)
Table 79. Global NSAIDs Revenue by Application (2023-2028) & (USD Million)
Table 80. Global NSAIDs Price by Application (2017-2022) & (USD/Pcs)
Table 81. Global NSAIDs Price by Application (2023-2028) & (USD/Pcs)
Table 82. North America NSAIDs Sales by Country (2017-2022) & (K Pcs)
Table 83. North America NSAIDs Sales by Country (2023-2028) & (K Pcs)
Table 84. North America NSAIDs Revenue by Country (2017-2022) & (USD Million)
Table 85. North America NSAIDs Revenue by Country (2023-2028) & (USD Million)
Table 86. North America NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 87. North America NSAIDs Sales by Type (2023-2028) & (K Pcs)
Table 88. North America NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 89. North America NSAIDs Sales by Application (2023-2028) & (K Pcs)
Table 90. Europe NSAIDs Sales by Country (2017-2022) & (K Pcs)
Table 91. Europe NSAIDs Sales by Country (2023-2028) & (K Pcs)
Table 92. Europe NSAIDs Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe NSAIDs Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 95. Europe NSAIDs Sales by Type (2023-2028) & (K Pcs)
Table 96. Europe NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 97. Europe NSAIDs Sales by Application (2023-2028) & (K Pcs)
Table 98. Asia-Pacific NSAIDs Sales by Region (2017-2022) & (K Pcs)
Table 99. Asia-Pacific NSAIDs Sales by Region (2023-2028) & (K Pcs)
Table 100. Asia-Pacific NSAIDs Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific NSAIDs Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 103. Asia-Pacific NSAIDs Sales by Type (2023-2028) & (K Pcs)
Table 104. Asia-Pacific NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 105. Asia-Pacific NSAIDs Sales by Application (2023-2028) & (K Pcs)
Table 106. South America NSAIDs Sales by Country (2017-2022) & (K Pcs)
Table 107. South America NSAIDs Sales by Country (2023-2028) & (K Pcs)
Table 108. South America NSAIDs Revenue by Country (2017-2022) & (USD Million)
Table 109. South America NSAIDs Revenue by Country (2023-2028) & (USD Million)
Table 110. South America NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 111. South America NSAIDs Sales by Type (2023-2028) & (K Pcs)
Table 112. South America NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 113. South America NSAIDs Sales by Application (2023-2028) & (K Pcs)
Table 114. Middle East & Africa NSAIDs Sales by Region (2017-2022) & (K Pcs)
Table 115. Middle East & Africa NSAIDs Sales by Region (2023-2028) & (K Pcs)
Table 116. Middle East & Africa NSAIDs Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa NSAIDs Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa NSAIDs Sales by Type (2017-2022) & (K Pcs)
Table 119. Middle East & Africa NSAIDs Sales by Type (2023-2028) & (K Pcs)
Table 120. Middle East & Africa NSAIDs Sales by Application (2017-2022) & (K Pcs)
Table 121. Middle East & Africa NSAIDs Sales by Application (2023-2028) & (K Pcs)
Table 122. NSAIDs Raw Material
Table 123. Key Manufacturers of NSAIDs Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. NSAIDs Typical Distributors
Table 127. NSAIDs Typical Customers
List of Figures
Figure 1. NSAIDs Picture
Figure 2. Global NSAIDs Revenue Market Share by Type in 2021
Figure 3. Aspirin
Figure 4. Ibuprofen
Figure 5. Naproxen
Figure 6. Nabumetone
Figure 7. Others
Figure 8. Global NSAIDs Revenue Market Share by Application in 2021
Figure 9. Back Pain Treatment
Figure 10. Osteoarthritis Treatment
Figure 11. Other Disease Treatment
Figure 12. Global NSAIDs Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 13. Global NSAIDs Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global NSAIDs Sales (2017-2028) & (K Pcs)
Figure 15. Global NSAIDs Price (2017-2028) & (USD/Pcs)
Figure 16. Global NSAIDs Production Capacity (2017-2028) & (K Pcs)
Figure 17. Global NSAIDs Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. NSAIDs Market Drivers
Figure 19. NSAIDs Market Restraints
Figure 20. NSAIDs Market Trends
Figure 21. Global NSAIDs Sales Market Share by Manufacturer in 2021
Figure 22. Global NSAIDs Revenue Market Share by Manufacturer in 2021
Figure 23. NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 NSAIDs Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 NSAIDs Manufacturer (Revenue) Market Share in 2021
Figure 26. Global NSAIDs Sales Market Share by Region (2017-2028)
Figure 27. Global NSAIDs Revenue Market Share by Region (2017-2028)
Figure 28. North America NSAIDs Revenue (2017-2028) & (USD Million)
Figure 29. Europe NSAIDs Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific NSAIDs Revenue (2017-2028) & (USD Million)
Figure 31. South America NSAIDs Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa NSAIDs Revenue (2017-2028) & (USD Million)
Figure 33. Global NSAIDs Sales Market Share by Type (2017-2028)
Figure 34. Global NSAIDs Revenue Market Share by Type (2017-2028)
Figure 35. Global NSAIDs Price by Type (2017-2028) & (USD/Pcs)
Figure 36. Global NSAIDs Sales Market Share by Application (2017-2028)
Figure 37. Global NSAIDs Revenue Market Share by Application (2017-2028)
Figure 38. Global NSAIDs Price by Application (2017-2028) & (USD/Pcs)
Figure 39. North America NSAIDs Sales Market Share by Type (2017-2028)
Figure 40. North America NSAIDs Sales Market Share by Application (2017-2028)
Figure 41. North America NSAIDs Sales Market Share by Country (2017-2028)
Figure 42. North America NSAIDs Revenue Market Share by Country (2017-2028)
Figure 43. United States NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe NSAIDs Sales Market Share by Type (2017-2028)
Figure 47. Europe NSAIDs Sales Market Share by Application (2017-2028)
Figure 48. Europe NSAIDs Sales Market Share by Country (2017-2028)
Figure 49. Europe NSAIDs Revenue Market Share by Country (2017-2028)
Figure 50. Germany NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific NSAIDs Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific NSAIDs Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific NSAIDs Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific NSAIDs Revenue Market Share by Region (2017-2028)
Figure 59. China NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America NSAIDs Sales Market Share by Type (2017-2028)
Figure 66. South America NSAIDs Sales Market Share by Application (2017-2028)
Figure 67. South America NSAIDs Sales Market Share by Country (2017-2028)
Figure 68. South America NSAIDs Revenue Market Share by Country (2017-2028)
Figure 69. Brazil NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa NSAIDs Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa NSAIDs Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa NSAIDs Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa NSAIDs Revenue Market Share by Region (2017-2028)
Figure 75. Turkey NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa NSAIDs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of NSAIDs in 2021
Figure 80. Manufacturing Process Analysis of NSAIDs
Figure 81. NSAIDs Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
